节点文献

99mTc—Dextran淋巴显像在恶性淋巴瘤诊断和治疗中的临床应用

Lymphoscintigraphy with 99mTc-Dextran in the Diagnosis and Treatment of Lymphoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张凤春张秀梅姜玉珍卢振霞赵美蓉罗云霄杨国珍

【Author】 Zhang Feng-Chun et alDepartment of Hematology/Oncology 3rd Teaching Hospital,Bethune University of Medical Sciences, Changchun, Jilin

【机构】 白求恩医科大学第三临床学院血液化疗科白求恩医科大学第三临床学院核医学科舒兰县医院核医学科 长春市130021长春市130021进修生

【摘要】 本文探讨了99mTc—Dextran淋巴显像在恶性淋巴瘤诊断和治疗中的应用.结果表明:(1)99mTc—Dextran淋巴显像有一定可靠性,对恶性淋巴瘤临床分期有较好应用价值,特别对腹膜后淋巴瘤更为重要,本组63.5%病人改变了临床分期,可指导临床治疗和判断疗效.(2)99mTc—Dextran淋巴显像可确定淋巴瘤所在淋巴链中位置,同时对检测淋巴回流也是一种较好的方法.(3)本方法不需破坏淋巴管,因此也是淋巴管内注入抗癌药物必要的筛选手段.

【Abstract】 Lymphoscintigraphy with 99mTc-Dextran is helpful in staging of lymphoma,especially for those situat-ed in retroperitoneum. 63. 5% of the patients in this series changed their clinical stage after lymphoscintigraphy. Meanwhile, 99mTc-Dextran besides its therapeutic effect also enables follow-up judgement following treatment. Lymphoscintigraphy with 99mTc-Dextran can define the involved lymph nodes in lymphatic chains, and is useful in assessing lymphosta-sis. Lymphoscintigraphy does not jeopardize lymphatic vessel, therefore, it provides an avenue to assess the therapeutic effect of chemotherapy.

  • 【文献出处】 中国肿瘤临床 ,Chinese Journal of Clinical Oncology , 编辑部邮箱 ,1994年04期
  • 【分类号】R733.1
  • 【下载频次】27
节点文献中: 

本文链接的文献网络图示:

本文的引文网络